EASL Wrap-up Session Highlighted Late-Breaking Clinical Data of First-in-class HBV-specific TCR T Cell Therapy (SCG101) Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma ...Middle East

SINGAPORE, June 7, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, announced that clinical data from its first-in-class autologous hepatitis B virus...

Hence then, the article about easl wrap up session highlighted late breaking clinical data of first in class hbv specific tcr t cell therapy scg101 showing improved overall survival in hbv related hepatocellular carcinoma was published today ( Friday 07/06/2024 - 11:49 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( EASL Wrap-up Session Highlighted Late-Breaking Clinical Data of First-in-class HBV-specific TCR T Cell Therapy (SCG101) Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma )

Also on site :

• Texas Roadhouse & Olive Garden among restaurants mandating strict ‘one ring’ policy for diner safety
• Alec Baldwin hits back at Elon Musk for criticizing Lupita Nyong’o’s looks amid ‘The Odyssey’ casting
• What to know about Panama at the FIFA World Cup 2026